As Accelerate Diagnostics INC (AXDX) Market Value Declined, Oracle Investment Management INC Has Upped Stake

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) LogoInvestors sentiment increased to 1.57 in 2019 Q2. Its up 0.44, from 1.13 in 2019Q1. It is positive, as 10 investors sold AXDX shares while 20 reduced holdings. 14 funds opened positions while 33 raised stakes. 27.92 million shares or 7.98% more from 25.86 million shares in 2019Q1 were reported. Citadel Advsrs Lc reported 102,626 shares. Morgan Stanley invested in 0% or 461,442 shares. Griffin Asset Mgmt owns 550,046 shares for 1.6% of their portfolio. Minnesota-based Next Century Growth Ltd Liability Corp has invested 0.64% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Amundi Pioneer Asset Mgmt holds 0% or 93,100 shares in its portfolio. California State Teachers Retirement System, a California-based fund reported 41,995 shares. Daiwa Securities Gru holds 8,000 shares. Bamco Ny reported 260,000 shares. Reilly holds 0% or 1,500 shares. Charles Schwab Investment Mngmt holds 154,013 shares. Ontario – Canada-based Royal Comml Bank Of Canada has invested 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Oz Mngmt Lp invested 0.01% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Vanguard Group Inc Inc has 1.39 million shares. California Pub Employees Retirement System owns 26,000 shares. First Republic holds 0.06% or 493,740 shares.

Oracle Investment Management Inc increased its stake in Accelerate Diagnostics Inc (AXDX) by 2010.64% based on its latest 2019Q2 regulatory filing with the SEC. Oracle Investment Management Inc bought 4.15M shares as the company’s stock declined 4.21% . The hedge fund held 4.36M shares of the capital goods company at the end of 2019Q2, valued at $99.67M, up from 206,400 at the end of the previous reported quarter. Oracle Investment Management Inc who had been investing in Accelerate Diagnostics Inc for a number of months, seems to be bullish on the $1.12B market cap company. The stock increased 0.79% or $0.16 during the last trading session, reaching $20.48. About 230,133 shares traded or 20.57% up from the average. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has declined 10.62% since September 13, 2018 and is downtrending. It has underperformed by 10.62% the S&P500.

Oracle Investment Management Inc, which manages about $877.33 million and $464.87M US Long portfolio, decreased its stake in Quidel Corp (NASDAQ:QDEL) by 118,294 shares to 1.79M shares, valued at $105.90M in 2019Q2, according to the filing.

More notable recent Accelerate Diagnostics, Inc. (NASDAQ:AXDX) news were published by: Seekingalpha.com which released: “Stocks To Watch: Eyes On Jackson Hole, Lyft And Disney D23 – Seeking Alpha” on August 17, 2019, also Seekingalpha.com with their article: “Accelerate Diagnostics announces preliminary Q4 and FY 2018 results – Seeking Alpha” published on January 07, 2019, Seekingalpha.com published: “Accelerate Diagnostics, Inc.: The Snowball Effect Is Just Beginning – Seeking Alpha” on August 09, 2019. More interesting news about Accelerate Diagnostics, Inc. (NASDAQ:AXDX) were released by: Seekingalpha.com and their article: “Accelerate Diagnostics (AXDX) Presents At Cowen and Company 39th Annual Health Care Conference – Slideshow – Seeking Alpha” published on March 13, 2019 as well as Finance.Yahoo.com‘s news article titled: “Accelerate Diagnostics (AXDX) Q1 2019 Earnings Call Transcript – Yahoo Finance” with publication date: May 10, 2019.

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.